ELOXATIN INJECTION 100mg/20ml vial contains Oxaliplatin, a chemotherapy medication used to treat certain types of cancer, primarily colorectal cancer. It works by interfering with the growth of cancer cells, ultimately leading to their destruction.
This medication is typically prescribed for patients with stage III colon cancer following surgery, as well as for patients with metastatic colorectal cancer. It may be used in combination with other chemotherapy agents to enhance treatment effectiveness.
ELOXATIN is administered via intravenous infusion. The dosage and treatment schedule are determined based on individual patient factors, including overall health and response to therapy.
Common side effects may include nausea, vomiting, diarrhea, fatigue, and peripheral neuropathy (tingling or numbness in the hands and feet). Patients should report any severe side effects or unusual symptoms to their healthcare provider immediately.
Prior to treatment, patients should inform their doctor of any allergies, existing medical conditions, or medications they are currently taking to avoid potential interactions. Regular monitoring is essential during treatment to manage side effects and assess effectiveness.
Store ELOXATIN in a cool, dry place away from light. Ensure that it is kept out of reach of children and disposed of properly after use.
Always consult with a healthcare professional for personalized advice and to discuss the benefits and risks associated with ELOXATIN treatment. Your healthcare provider will provide guidance tailored to your specific health needs.